Seeking Alpha

Portola Pharmaceuticals beats by $0.02, misses on revenue

  • Portola Pharmaceuticals (NASDAQ:PTLA): Q2 EPS of -$0.76 beats by $0.02.
  • Revenue of $2.42M (-6.9% Y/Y) misses by $0.02M.
  • Press Release

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs